Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Ipca Laboratories
Pharmaceutical Preparation ManufacturingIndiaNSE: IPCALAB.NS
Last verified 11 months agoipca.com
Ipca Laboratories Limited, commonly referred to as Ipca, stands as a leading global pharmaceutical company, founded in 1949. Headquartered in India, this enterprise has consistently contributed to the healthcare industry, marking decades of growth and innovation within pharmaceutical preparation manufacturing.
Specialising in the development and production of Active Pharmaceutical Ingredients (APIs) and a diverse portfolio of finished pharmaceutical formulations, Ipca addresses critical healthcare needs. Its robust manufacturing capabilities and commitment to quality ensure a reliable supply of essential medicines worldwide.
With a significant global footprint, operating in over 100 countries, Ipca has established itself as a trusted name in pharmaceuticals. The company's market position reflects its dedication to providing accessible, high-quality therapeutic solutions, thereby enhancing patient well-being across the globe.
56
DitchCarbon score
+14 vs industry average
Ipca Laboratories’s score of 56 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Ipca Laboratories?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2028
202020212022202320242025202620272028
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Ipca Laboratories's reported carbon emissions
Ipca Laboratories, a Pharmaceutical Preparation Manufacturing company headquartered in India, reported estimated total emissions of approximately 582.4 million kg CO2e in 2025. This includes about 170.0 million kg CO2e from Scope 1, 124.5 million kg CO2e from Scope 2, and 287.9 million kg CO2e from Scope 3. In the preceding year, 2024, their estimated total emissions were approximately 618.5 million kg CO2e, comprising around 174.5 million kg CO2e from Scope 1, 137.3 million kg CO2e from Scope 2, and 306.7 million kg CO2e from Scope 3. For 2023, the company reported approximately 124.9 million kg CO2e for Scope 1 emissions and 179.1 million kg CO2e for Scope 2 emissions, without disclosing Scope 3 data. In 2022, Ipca Laboratories reported approximately 151.9 million kg CO2e for Scope 1 emissions and 174.7 million kg CO2e for Scope 2 emissions, also without disclosing Scope 3 data.
Ipca Laboratories is committed to climate action, with a near-term target to reduce its Scope 1 and 2 carbon emissions by 20% by 2030, using 2022 as the baseline year. The company is also listed as "Committed" to net-zero by the Science Based Targets initiative (SBTi). All reported emissions data and reduction targets are directly from Ipca Laboratories Limited.
Assessing Ipca Laboratories as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Ipca Laboratories and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Ipca Laboratories’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Ipca Laboratories11 months ago
56
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Frequently asked questions
Common questions about Ipca Laboratories’s sustainability data and climate commitments
Ipca Laboratories reported approximately 582.4 million kg CO2e in total emissions for 2025. This figure is comprised of roughly 170.0 million kg CO2e from Scope 1, about 124.5 million kg CO2e from Scope 2, and approximately 287.9 million kg CO2e from Scope 3. The company's Scope 3 emissions represent the largest portion of its carbon footprint, highlighting the significance of its supply chain and other indirect activities in its overall environmental impact. These figures are directly reported by Ipca Laboratories.
Data year: 2025
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more